Link-Gov.Org - How NHS Next Stage Review Relates To NICE

Home

Publications

All Publications

How NHS Next Stage Review Relates To NICE

NICE welcomes NHS Next Stage Review final report

The key recommendations in the report relating to NICE are:

    * All patients will receive drugs and treatments approved by NICE if their clinician recommends them.
    * NICE technology appraisal process are to be speeded up. Our process for appraising new drugs and treatments is widely acknowledged as being the gold standard against which other organisations and countries measure themselves. We want NICE guidance to be available to patients and NHS staff as, or shortly after, treatments become available for use in the NHS. Because we have not always been able to do this, we welcome the opportunity to work with the Department of Health on measures for speeding up the process, from the selection of topics by the Department of Health through to publication of final guidance.
    * NICE will host and manage NHS Evidence, a service that will help NHS professionals keep up to date with best practice in order to deliver excellent care. NHS Evidence will be a new, single portal, through which anyone will be able to access clinical and non-clinical evidence and information about best practice: both what high quality care looks like and how to deliver it. Greater clarity on standards, and where to go to find them, will support the commissioning and uptake of the most clinically and cost-effective diagnostics, treatments and procedures.
    * NICE has been asked to work with professional and patient groups in overseeing an independent and transparent process for developing and reviewing the Quality and Outcome Framework (QOF) indicators, and discussing with the BMA and others how to refocus QOF more on health promotion, clinical quality and health outcomes.
    * NICE will be responsible for independent quality standards and clinical priority setting. From 2009, the responsibilities of NICE will be expanded to include setting and approving more independent quality standards. A new National Quality Board will offer transparent advice to Ministers on priorities for clinical standard setting by NICE.
    * A NICE fellowship programme will be set up. NICE will continue to work openly and collaboratively in partnership at national level and with frontline NHS staff. For frontline clinicians, working with NICE is already considered a valuable opportunity for professional development. NICE will be even more proactive in reaching out to local clinical communities as well as national ones. The fellowship programme will be a key part of the new initiatives.

Andrew Dillon, NICE Chief Executive, commented:

‘We welcome the report as we believe it represents a strong endorsement of NICE and the confidence and trust we have worked hard to build in the NHS. The additional work we are being given fits well with our current remit and is in line with our own vision for the future. Over the next couple of months we will be working closely with the Department of Health and our other partners to determine exactly how we will deliver these recommendations and by doing so, help to bring about a truly evidence-based, quality driven NHS.

» No Comments

There are no comments up to now.

» Post Comment

< Prev		Next >

[ Back ]

COI News Distribution Service

Companies

Politics

European Commission

Supported by

Random Image

No Images